Function and survival of intrasplenic islet autografts in dogs

Diabetologia. 1996 Jan;39(1):37-44. doi: 10.1007/BF00400411.

Abstract

Successful transplantation of isolated islets of Langerhans has been reported in large mammals, including man, but metabolic control has not been well-established. We studied the glucose and islet hormone response to fasting, i.v. glucose bolus infusion, i.v. arginine bolus infusion during a 35-mmol/l hyperglycaemic clamp, mixed meals, and i.v. insulin-induced hypoglycaemia up to 3 years after intrasplenic islet autotransplantation in six pancreatectomised dogs. The individual postprandial insulinogenic index (ratio of 2-h postprandial insulin to glucose levels) at 1 month post-transplant, predicted (r = 0.99) the time to functional graft failure (6-175 weeks). Metabolic studies at 6 months post-transplant in four dogs demonstrated normal fasting glucose and hormone levels, except for reduced pancreatic polypeptide levels. Intravenous glucose and arginine-stimulated insulin were reduced to 15% of preoperative values. In contrast, postprandial normoinsulinaemia was observed--albeit with moderate hyperglycaemia (approximately 10 mmol/l). Postprandial glucagon and glucose-dependent insulinotropic polypeptide (GIP) had increased. Comparison of the post-transplant insulin responses to a meal and to intravenous challenges demonstrated maximal stimulation of the graft by the meal. Post-transplant pancreatic polypeptide responses to a meal and i.v. arginine were severely reduced, and no pancreatic polypeptide response to i.v. insulin-induced hypoglycaemia was observed--indicating absence of cholinergic reinnervation. Thus, glucose regulation and both the insulin secretory capacity and life expectancy of islet grafts were best documented by meal testing. Tentatively, a postprandial hyperglycaemia-enhanced incretin effect of glucose-dependent insulinotropic polypeptide and other gut hormones may account for the difference in the insulin response to i.v. glucose and a meal. Aside from the reduced insulin secretory capacity, both a deranged pulsatile delivery of insulin, hyperglucagonaemia, and pancreatic polypeptide deficiency may have been conducive to glucose intolerance.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / pharmacology
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Dogs
  • Eating
  • Female
  • Gastric Inhibitory Polypeptide / blood
  • Glucagon / blood
  • Glucose Tolerance Test
  • Graft Survival*
  • Hypoglycemia
  • Insulin / blood
  • Insulin / metabolism
  • Insulin / pharmacology
  • Insulin Secretion
  • Islets of Langerhans Transplantation / immunology
  • Islets of Langerhans Transplantation / physiology*
  • Pancreatic Polypeptide / blood
  • Spleen
  • Time Factors
  • Transplantation, Autologous
  • Transplantation, Heterotopic

Substances

  • Blood Glucose
  • Insulin
  • Gastric Inhibitory Polypeptide
  • Pancreatic Polypeptide
  • Glucagon
  • Arginine